Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000238509 | SCV000294489 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Molecular Genetics Laboratory, |
RCV000238509 | SCV000540719 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-11-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001857819 | SCV002246581 | pathogenic | Familial hypercholesterolemia | 2021-10-05 | criteria provided, single submitter | clinical testing | This variant is also known as p.Gln32X. This premature translational stop signal has been observed in individual(s) with familial hypercholesterolemia (PMID: 16250003, 16792510). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln53*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). ClinVar contains an entry for this variant (Variation ID: 251039). For these reasons, this variant has been classified as Pathogenic. |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000238509 | SCV000606028 | pathogenic | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |